InvestorsHub Logo
Followers 145
Posts 27561
Boards Moderated 3
Alias Born 02/07/2004

Re: midastouch017 post# 1357

Monday, 02/13/2017 1:03:06 PM

Monday, February 13, 2017 1:03:06 PM

Post# of 2808
BioLineRx perks up 7% on Rodman bullish call

Feb. 13, 2017 12:49 PM ET|About: BioLineRx Ltd. (BLRX)|By: Douglas W. House, SA News Editor
Thinly traded nano cap BioLineRx (BLRX +7.3%) is up on more than a 4x surge in volume on the heels of Rodman & Renshaw's initiation of coverage with a Buy rating and $3 (154% upside) price target.

The company's lead product candidate is Phase 2-stage cancer therapeutic BL-8040.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BLRX News